InvestorsHub Logo
Followers 34
Posts 2484
Boards Moderated 0
Alias Born 02/04/2013

Re: None

Wednesday, 03/01/2023 2:51:19 PM

Wednesday, March 01, 2023 2:51:19 PM

Post# of 461402
My question is how does RETA get a P2 approval with just 102 patients patients for a rare disease and we just keep getting no love from the FDA.
https://www.reatapharma.com/our-science/default.aspx#pipeline
How in the world does this happen or do we have a management team that just doesn't have the clout that other small companies do. Can someone please give us an honest opinion as to why our Rett program is not approved for at least adult use but their P2 gets approval and about a $2B bump in market cap. Did the fda just kick the can down the road and said do the pediatric also which delayed us about a year? Why didn't we go for approval when we had the P3 data. Did we have to do the pediatric or could we have forced the fda to approve the adult first. This does not make sense to me.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News